Purchases and Sales Made in Q4 2024 in Nautilus Biotechnology, Inc. (NAUT)
This table provides information about the institutional ownership of Nautilus Biotechnology, Inc. (NAUT) during Q4 2024. The information is specifically focused on institutions that hold shares of Nautilus Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 06, 2025
Q4 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-22.3K- 16.19% |
$37.2K - $65.9K
|
115K
$103K
|
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-32.7K- 6.44% |
$54.6K - $96.8K
|
475K
$423K
|
|
|
Feb 05, 2025
Q4 2024
|
Sentinel Trust CO Lba
Houston, TX |
SELL
|
- |
-60K- 19.05% |
$100K - $178K
|
255K
$227K
|
|
|
Feb 14, 2025
Q4 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-188K- 42.53% |
$313K - $555K
|
253K
$226K
|
|
|
Feb 14, 2025
Q4 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-241K- 12.05% |
$402K - $713K
|
1.76M
$1.57M
|